Skip to main content
Signal8

Wexler William A.

SEC insider (Form 3/4/5 filer). CIK 0001927975. Director at Ernexa Therapeutics Inc. (ERNA). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in CAMBRIDGE, MA.

Companies Wexler William A. has filed insider reports for

  • Ernexa Therapeutics Inc. (ERNA): Director
Wexler William A. profile photo

Wexler William A.

CIK: 0001927975

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ernexa Therapeutics Inc. logo
ERNA

Ernexa Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Ernexa Therapeutics Inc. logo
    ERNA

    Ernexa Therapeutics Inc.

    Aug 31, 2026
    Award

    Stock Option (Right to buy)

    Direct
    5.9K shares-
  • Eterna Therapeutics Inc. logo
    ERNA

    Eterna Therapeutics Inc.

    Feb 7, 2025
    Award

    Stock Option (right to buy)

    Direct
    124.5K shares-

1-2 of 2